Call Me - +39 3381508675 - E-Mail: info@cyberpharmaexcellence.com

  • CONTACTS
  • SUBSCRIBE TO MAILING LIST

CYBERPHARMA EXCELLENCE

 

"The exchange of information between Pharma companies in the industry"

 

  • HOME
  • NEWS - EVENTS
    • EVENTS
    • COURSES & CONGRESSES
    • PARTNERS NEWS
    • REGULATORY NEWS
    • PHARMACOVIGILANCE
    • MINISTRY OF HEALTH
    • CYBERPHARMA EXCELLENCE NEWS
  • CM
    • DRUGS
    • COSMETICS
    • DIETARY
    • MEDICAL DEVICE
    • DATA BANKS
  • MARKET PLACE
    • OFFERS
    • REQUESTS
    • PARTNERSHIP
  • PARTNERS
    • INDEX
      • 1. PHARMACEUTICAL
        • 1.1 Raw materials
        • 1.2 Pharmaceutical Products
        • 1.3 Homeopathic Products
        • 1.4 Medical Devices
        • 1.5 Cosmetic Products
        • 1.6 Dietetic and Herbal Products
        • 1.7 Contract manufacturing production - DRUGS
        • 1.8 Contract manufacturing Production - Supplements - Cosmetics - Med. devices
        • 1.9 Machinery and Equipment
      • 2. CONTROLS, ANALYSIS AND RESEARCH
      • 3. LOGISTICS
      • 4. PACKAGING
      • 5. ORGANIZATION AND TECHNICAL CONSULTANCY
      • 6. REGULATORY AFFAIRS
      • 7. MARKETING
      • 8. HUMAN RESOURCES
      • 8.1 TECHNICAL MAGAZINES
      • 9. GENERAL SERVICES
      • 10. TRAINING COURSES
  • BECOME PARTNER
    • PARTICIPATION IN EVENTS
    • ADV-WEB
    • THE CYBERPHARMAEXCELLENCE ® PARTNER
    • NETWORK PARTNERS
      • Cybermed Europe
      • Cybermed News
      • Cybermed Junior
      • Cybermed Life
    • WORK WITH US
  • CONVENTIONS
    • BOOKS & MAGAZINES
    • HOTELS & CONFERENCE CENTERS
    • PATENTS
    • TRANSLATIONS
    • INSURANCES
    • FUNDING
    • WEBSITES & ICT SERVICES
How to resolve AdBlock issue?
Refresh this page
Filters
List of articles in category CYBERPHARMA EXCELLENCE NEWS
Title Author Hits
Resistenza antimicrobica, oltre 20 aziende biofarmaceutiche investono 1 miliardo di dollari per la ricerca Written by Cyberpharmaexcellence Hits: 1549
Nuova strategia farmaceutica Ue, in arrivo una rivoluzione Written by Cyberpharmaexcellence Hits: 1685
Spesa farmaceutica Ssn 2019, calo dello 0,2% rispetto a 2018 Written by Cyberpharmaexcellence Hits: 1517
Farmaci a base di Montelukast, Aifa: rischio insorgenza effetti indesiderati di tipo neuropsichiatrico Written by Cyberpharmaexcellence Hits: 1539
Farmindustria, Scaccabarozzi confermato alla guida: usiamo il Mes per investire in ricerca Written by Cyberpharmaexcellence Hits: 1545
Indagine sieroprevalenza, farmacie impegnate come principale presidio sanitario Written by Cyberpharmaexcellence Hits: 1576
Farmaci per epilessia, vademecum Lice per vacanze sicure Written by Cyberpharmaexcellence Hits: 1619
Covid-19, Ue autorizza Remdesivir per trattamento in tempo record Written by Cyberpharmaexcellence Hits: 1593
Coronavirus, documento Coalizione delle autorità regolatorie farmaci: No a studi su pochi pazienti Written by Cyberpharmaexcellence Hits: 1627
Oppioidi, arriva il no dall’Aifa per l’utilizzo in caso di dolore lieve Written by Cyberpharmaexcellence Hits: 1419

Page 8 of 16

  • Start
  • Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Next
  • End
How to resolve AdBlock issue?
Refresh this page

 

CYBERPHARMA EXCELLENCE

bY - M.A.B. Art Decò

Piazzale A. La Marmora, 13
01030 Monterosi (VT) ITALY
P.IVA: 08724920585

N° ROC REGISTER: 21797

 

 

Facebook

Follow us on facebook

qr-code

Cookie

Cookie Policy

Privacy

Privacy Policy

Visitorcounter

All 724322

Currently are 12 guests and no members online

GDPR Data Collection

GDPR

Copyright Cyberpharma Excellence © 2020. All Rights Reserved.

Back to top